| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| LAP |
|
Laryngeal adductor paralysis
|
|
|
0.619 |
0.731 |
| TRS-AGA2-3 |
|
tRNA-Ser (anticodon AGA) 2-3
|
|
|
0.743 |
0.385 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| MIR100 |
|
microRNA 100
|
|
|
0.521 |
0.846 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR132 |
|
microRNA 132
|
|
|
0.485 |
0.846 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |
| MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR150 |
|
microRNA 150
|
|
|
0.455 |
0.808 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR17 |
|
microRNA 17
|
|
|
0.459 |
0.846 |
| MIR185 |
|
microRNA 185
|
|
|
0.551 |
0.808 |